Skip to content
akaturk Academic measurement
2025 SJR Q2 JCR Q3 · 2,4 9 matched articles SCIE

Journal detail

Current Vascular Pharmacology

Publisher
Bentham Science Publishers
Country
United Arab Emirates · Middle East
Type
journal
ISSN
  • 15701611
  • 18756212
Scopus 0,601 SJR
Scopus Q2 SJR Q
WoS Q3 JCR Q
WoS 2,4 JIF
Scopus 76 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,601
  • Quartile Q2
  • H-Index 76
  • Cites/doc 2,06
  • Docs (3y) 154
  • Cites (3y) 273

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q3
  • JIF 2,4
  • 5Y JIF 3,6
  • JCI 0,4

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

  • Cardiology and Cardiovascular Medicine Q2
  • Pharmacology Q3

Areas

  • Medicine
  • Pharmacology, Toxicology and Pharmaceutics

WoS categories

  • Pharmacology & Pharmacy | Peripheral Vascular Diseases

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q2 Q3 0,601 2,4 3,6 0,4 Q3 76
2024 Q2 Q3 0,726 2,1 3,9 0,5 Q3 71
2023 Q1 Q2 0,991 2,8 3,5 0,66 Q2 71
2022 Q1 Q2 0,917 4,5 3,8 0,67 Q2 71
2021 Q2 Q3 0,67 3,5 3,4 0,6 Q2 71
2020 Q2 Q3 0,806 2,7 3 0,62 Q2 71
2019 Q2 Q3 0,559 2,7 2,2 0,63 Q2 71
2018 — Q3 — 2,6 2,5 0,63 Q2 —
2017 Q2 Q3 0,715 2,1 2,1 0,74 Q2 71
2016 Q2 Q3 0,89 2,4 2,3 — — 71
2015 Q2 Q2 0,897 2,4 2,2 — — 71
2014 Q2 Q2 0,828 3 3 — — 71
2013 Q2 Q2 0,783 2,9 2,8 — — 71
2012 Q1 Q2 0,975 2,8 2,9 — — 71
2011 Q1 Q2 0,944 2,9 2,6 — — 71
2010 Q1 Q1 1,04 3,2 3 — — 71
2009 — Q2 — 3 3,3 — — —
2008 — Q1 — 3,6 3,4 — — —
2007 — Q1 — 4,1 3,5 — — —
2006 — Q1 — 3,9 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 53/100
2025 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 215/356
2024 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q3 53/98
2024 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 222/352
2023 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 31/96
2023 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 158/354
2022 PERIPHERAL VASCULAR DISEASE SCIE Q2 Q2 22/68
2022 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 76/278
2021 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 34/67
2021 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 146/279
2020 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 40/65
2020 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 181/276
2019 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 33/65
2019 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 139/271
2018 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 33/65
2018 PHARMACOLOGY & PHARMACY SCIE Q3 Q3 134/267
2017 PERIPHERAL VASCULAR DISEASE SCIE Q3 Q2 42/65
2017 PHARMACOLOGY & PHARMACY SCIE Q3 Q2 164/261
2016 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 39/63
2016 PHARMACOLOGY & PHARMACY SCIE Q3 — 131/257
2015 PERIPHERAL VASCULAR DISEASE SCIE Q3 — 36/63
2015 PHARMACOLOGY & PHARMACY SCIE Q2 — 126/255
2014 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 23/60
2014 PHARMACOLOGY & PHARMACY SCIE Q2 — 84/255
2013 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 27/65
2013 PHARMACOLOGY & PHARMACY SCIE Q2 — 85/256
2012 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 24/68
2012 PHARMACOLOGY & PHARMACY SCIE Q2 — 87/261
2011 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 19/68
2011 PHARMACOLOGY & PHARMACY SCIE Q2 — 86/261
2010 PERIPHERAL VASCULAR DISEASE SCIE Q1 — 17/68
2010 PHARMACOLOGY & PHARMACY SCIE Q2 — 70/252
2009 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 20/61
2009 PHARMACOLOGY & PHARMACY SCIE Q2 — 76/237
2008 PERIPHERAL VASCULAR DISEASE SCIE Q2 — 16/56
2008 PHARMACOLOGY & PHARMACY SCIE Q1 — 50/219
2007 PERIPHERAL VASCULAR DISEASE SCIE Q1 — 12/54
2007 PHARMACOLOGY & PHARMACY SCIE Q1 — 28/205
2006 PERIPHERAL VASCULAR DISEASE SCIE Q1 — 11/52
2006 PHARMACOLOGY & PHARMACY SCIE Q1 — 36/199